• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov5
AC Immune released FY2025 Q3 earnings on November 4 (EST), actual revenue USD 1.177 M (forecast USD 1.011 M), actual EPS USD -0.2006 (forecast USD -0.2294)
04:00
AC Immune released FY2025 9 Months earnings on November 4, 2025 (EST), actual revenue USD 3.933 M, actual EPS USD -0.6788
04:00
Aug6
AC Immune released FY2025 Semi-Annual Earnings on August 5, 2025 (EST) with actual revenue of USD 2.738 M and EPS of USD -0.477
03:00
AC Immune released FY2025 Q2 earnings on August 5 (EST), actual revenue USD 1.633 M (forecast USD 2.479 M), actual EPS USD -0.2625 (forecast USD -0.2188)
03:00
May15
AC Immune Rating Upgraded but Target Price Cut
07:41
May6
HC Wainwright Raises AC Immune's Q2 2025 Earnings Outlook
06:04

Schedules & Filings

Schedules
Filings
Nov4
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 1.177 M, Net Income -19.89 M, EPS -0.2006

Aug5
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 1.633 M, Net Income -26.49 M, EPS -0.2632

Apr30
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 1.123 M, Net Income -21.58 M, EPS -0.2149

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
BBGI
16.690
+312.10%
+12.640
SRV.RT
0.0900
+111.76%
+0.048
BEAT
1.550
+92.43%
+0.745
ENVB
10.330
+74.49%
+4.410
BDRX
6.720
+65.11%
+2.650
ASPC
16.810
+60.40%
+6.330
IRBT
5.240
+48.44%
+1.710
CGTL
0.9727
+47.40%
+0.313
MIGI
6.700
+45.65%
+2.100
PLAB
37.350
+45.39%
+11.660
View More